Related Experiment Video
Updated: Dec 8, 2025

12:18
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
23.4K
Kasabach-Merritt phenomenon with cellulitis in infant
Ariyati Yosi1, Abdullah Afif Siregar2, Yasmine Siregar2
1Department of Dermatology and Venereology, Universitas Sumatera Utara Fakultas Kedokteran, Medan, Indonesia yosiariyati@gmail.com.
BMJ Case Reports
|September 16, 2020
Summary
Kasabach-Merritt phenomenon (KMP), a rare coagulopathy in vascular tumors like KHE, presents unique challenges. Early diagnosis and combination therapy with corticosteroids and propranolol offer improved outcomes.
Area of Science:
- Pediatric Hematology
- Vascular Anomalies
- Coagulopathy
Background:
- Kasabach-Merritt phenomenon (KMP) is a severe coagulopathy associated with specific vascular tumors, namely kaposiform hemangioendothelioma (KHE) and tufted angioma.
- This condition carries a high mortality rate and commonly affects the trunk, limbs, and retroperitoneum, presenting with symptoms like purpura, edema, and ecchymosis.
Observation:
- A 9-month-old boy presented with a rapidly enlarging violaceous leg tumor present since birth, leading to limb discrepancy.
- The tumor worsened with alternative massage treatments, resulting in bruising and wounds.
- Clinical presentation included severe thrombocytopenia, normocytic anemia, and elevated D-dimer levels, indicative of KMP with superimposed cellulitis.
Findings:
- The patient was diagnosed with Kasabach-Merritt phenomenon (KMP) complicated by cellulitis.
- Laboratory findings revealed severe thrombocytopenia and elevated D-dimer, confirming consumptive coagulopathy.
- Successful treatment involved a combination of oral corticosteroids, propranolol, and antibiotics.
Implications:
- This case highlights the importance of early clinical and laboratory diagnosis of KMP.
- Combination therapy using corticosteroids and propranolol demonstrates a viable treatment strategy for KMP.
- Prompt management is crucial for improving prognosis in infants with KMP and associated vascular lesions.

